Stada And Bio-Thera Add To Biosimilars Alliance With Tocilizumab

Deal For RoActemra Rival Builds On Golimumab Partnership

 
• By Dave Wallace
  
Bio-Thera will supply its tocilizumab biosimilar to Stada (Shutterstock)

More from Deals

More from Business